‘Tremendous potential’: Cell therapy shows promise in treating deadly brain cancer in new trial
A clinical trial showed CAR-T cell therapy may shrink aggressive brain and spinal cord tumours in young patients. View on ...
AZoLifeSciences on MSN19h
A Closer Look at CAR T-Cell Therapy — Successes, Challenges, And Future
T-cell therapy is a revolutionary immunotherapy approach in which T cells are genetically modified to express a receptor that ...
BioTechniques1d
Next-gen CAR-T therapy: innovations, challenges and future directions
The process begins with the collection of a patient’s T cells. Then these T cells are genetically modified to express ...
Promising Developments and Financial Stability Drive Buy Rating for CARGO Therapeutics
Chardan Capital analyst Geulah Livshits reiterated a Buy rating on CARGO Therapeutics, Inc. (CRGX – Research Report) today and set a ...
The American Journal of Managed Care7d
KIR2DS2+ NK Cells Show Potential in HCC and Leukemia Treatment
These findings suggest that KIR2DS2-positive (KIR2DS2+) natural killer (NK) cells could be an attractive therapeutic target ...
MedPage Today on MSN6d
Overcoming the Challenges of Applying CAR T-Cell Therapy to Solid Tumors
Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window ...
emjreviews.com4d
Low Prevalence of Serious Cardiovascular Events in CAR T-Cell Therapy Recipients
A recent meta-analysis investigating cardiovascular complications in adults undergoing chimeric antigen receptor (CAR) T-cell ...
Medical Xpress23d
New CAR-T cells offer on-demand control for cancer treatment
Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells—a type of cancer immunotherapy—that can be switched on to varying degrees of intensity and ...
Morningstar22d
Interius BioTherapeutics Doses First Patient with in vivo Chimeric Antigen Receptor (CAR) Gene Therapy for B-cell Malignancies
INT2104 is a novel in vivo chimeric antigen receptor (CAR) gene therapy designed to generate CAR-T and CAR-NK cells in the patient’s body to target CD20-expressing malignant B cells Interim ...
News Medical on MSN8d
Modulating CD39 expression to enhance CAR-T cell therapy against hepatocellular carcinoma
In the quest to enhance the efficacy of chimeric antigen receptor T (CAR-T) cell therapy against hepatocellular carcinoma (HCC), a recent study has identified a pivotal role for CD39 expression in ...